Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (272 million pounds) spanning five years due to Washington's demand for sensitive data.
This rejection was revealed after a official document from December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman has since stated that the US was requesting health data for research and commercial gain while refused to share the benefits from any future medical innovations.
"We will now turn to the challenging and unfortunate process of scaling back our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to find a agreement acceptable to both sides so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This development comes after a similar situation in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the safety of citizens' health data.
After returning to office recently, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had overseen aid for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing government-to-government agreements to boost transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to similar health pacts, constituting more than $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment through American-funded programmes," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.
"Put simply, our country would provide the raw materials for scientific discovery with no certainty that the final treatments would be accessible to our citizens should a new disease outbreak arise."
Sovereignty and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting systems previously set up through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how subsequent collaboration could be arranged in a way that honours the independence and dignity of each country."
Health Experts Reaction
Medical experts said it understood the government's concerns, but suggested that negotiations should continue given that a large portion of the nation's Aids initiatives were funded by external financing.
"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can frequently be resolved via detailed discussion and mutually agreed protections," the group added.
The halted deal highlights the continuing challenges between receiving vital foreign assistance and protecting local interests in an ever more data-driven world.